COVID-19

Novel coronavirus (COVID-19)-positive patients with traumatic injuries have six times higher risk of death and complication than patients without

A comprehensive molecular study of the brains of people who died of the novel coronavirus (COVID-19) found clear signs of inflammation and impaired

The Pfizer/BioNTech novel coronavirus (COVID-19) vaccination is “highly effective” against the Delta variant, Reuters reported late last

The novel coronavirus (COVID-19) vaccinations producer by Pfizer/BioNTech and Moderna likely produce an immune response that is strong and

Epstein-Barr virus (EBV) reactivation resulting from the inflammatory response to novel coronavirus (COVID-19) infection may be the cause of

The novel coronavirus (COVID-19) variant B.1.617.2, also known as the Delta variant, could be dominant in the United States in a few weeks, according

Novel coronavirus (COVID-19) therapies made from combinations of two antibodies are effective against a wide range of variants of the virus,

SARS-CoV-2, the virus that causes the novel coronavirus (COVID-19), may have the ability to reactivate dormant tuberculosis (TB), and infection with